BIO · ASX

Biome Australia Ltd (ASX:BIO)

AU$0.46

 -0.015 (-3.158%)
ASX:Live
18/09/2025 03:51:51 PM
HALO Ords HALO Consensus Value HALO Capital Efficiency GROWTH AUS Consensus Cheap +2
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

BIO Overview

BIO Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Weak

GARP

Very Weak

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Weak

About BIO

Website

N/A

Telephone

61.3.9017.5800

Address

192-194 Johnston Street Collingwood, Victoria (VIC) 3066

Description

Biome Australia Ltd. engages in the research, development, manufacture, and distribution of evidence-based products linking the gut and human health. It offers live biotherapeutics products and complementary medicines under the Activated Probiotic brand. The company was founded by Blair Vega Norfolk on July 6, 2018 and is headquartered in Collingwood, Australia.

BIO Price Chart

Key Stats

Market Cap

AU$104.79M

PE

545.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.38 - 0.87

Trade Value (12mth)

AU$66,126.00

1 week

0%

1 month

-12.04%

YTD

-20.83%

1 year

-35.37%

All time high

0.87

Key Fundamentals

EPS 3 yr Growth

-104.40%

EBITDA Margin

1.50%

Operating Cashflow

-$3m

Free Cash Flow Return

-72.30%

ROIC

5.50%

Interest Coverage

1.40

Quick Ratio

1.00

Other Data

Shares on Issue (Fully Dilluted)

N/A

HALO Sector

Healthcare

Next Company Report Date

01-Sep-26

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

BIO Announcements

Latest Announcements

Date Announcements

03 September 25

Q1 FY26 Revenue Guidance

×

Q1 FY26 Revenue Guidance

02 September 25

Biome Secures New Zealand Pharmacy Deal

×

Biome Secures New Zealand Pharmacy Deal

28 August 25

Biome Secures Distribution with Mecca and GoVita

×

Biome Secures Distribution with Mecca and GoVita

27 August 25

Preliminary Final Report

×

Preliminary Final Report

27 August 25

Financial Year 2025 Preliminary Results

×

Financial Year 2025 Preliminary Results

06 August 25

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

29 July 25

Quarterly Activities & Cashflow Report

×

Quarterly Activities & Cashflow Report

28 July 25

Biome Australia Investor Webinar

×

Biome Australia Investor Webinar

15 July 25

International Market Update and New Distribution Agreements

×

International Market Update and New Distribution Agreements

09 July 25

Response to ASX Cleansing Notice Timing Letter

×

Response to ASX Cleansing Notice Timing Letter

01 July 25

Biome Achieves Record Sales Revenue

×

Biome Achieves Record Sales Revenue

30 June 25

Application for quotation of securities - BIO

×

Application for quotation of securities - BIO

30 June 25

Application for quotation of securities - BIO

×

Application for quotation of securities - BIO

30 June 25

Secondary Trading Notice

×

Secondary Trading Notice

25 June 25

Proposed issue of securities - BIO

×

Proposed issue of securities - BIO

29 May 25

Investor Webinar

×

Investor Webinar

21 May 25

Board Update

×

Board Update

21 May 25

Final Director's Interest Notice

×

Final Director's Interest Notice

06 May 25

Biome Launches Activated Therapeutics Range

×

Biome Launches Activated Therapeutics Range

30 April 25

Activated Probiotics New Product Launches

×

Activated Probiotics New Product Launches

28 April 25

Quarterly Activities & Cashflow Report

×

Quarterly Activities & Cashflow Report

08 April 25

Change of Director's Interest Notice

×

Change of Director's Interest Notice

03 April 25

Biome secures $5 million debt facilities with NAB

×

Biome secures $5 million debt facilities with NAB

02 April 25

Biome reports strong sales revenue for Q3 FY25

×

Biome reports strong sales revenue for Q3 FY25

04 March 25

Change of Director's Interest Notice

×

Change of Director's Interest Notice

04 March 25

Application for quotation of securities - BIO

×

Application for quotation of securities - BIO

BIO Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.02 -0.01 0.00 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.02 -0.01 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock 32.6 47.7 112.5 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A 545.0 Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.01 -0.00 0.00 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.02 -0.00 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 21.5 62.6 179.7 Lock Lock Lock
     Yield % Lock Lock Lock Lock -27.0 -0.2 -2.9 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.02 0.01 0.02 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.02 0.01 0.02 Lock Lock Lock
     Growth % Lock Lock Lock Lock -45.6 -24.0 51.5 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 201 208 218 Lock Lock Lock
Basic m Lock Lock Lock Lock 201 208 218 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Income Statement
Sales $m Lock Lock Lock Lock 7 13 18 Lock Lock Lock
     Growth % Lock Lock Lock Lock 75.5 79.8 41.6 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 7 10 11 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 4 8 11 Lock Lock Lock
     Growth % Lock Lock Lock Lock 76.0 89.1 43.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock 56.0 59.0 59.8 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 44 41 40 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -3 -2 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock 26.2 45.3 116.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock -42.3 -12.9 1.5 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -3 -2 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock 22.5 41.6 101.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock -45.3 -14.7 0.2 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -3 -2 0 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -3 -2 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock 32.2 45.7 112.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock -42.5 -12.8 1.2 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -3 0 -3 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 1 1 3 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -4 0 -3 Lock Lock Lock
     Growth % Lock Lock Lock Lock -9.8 95.2 -1,440.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock -0.5 -0.0 -0.2 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 2 3 3 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 8 8 12 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 1 0 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -1 -2 0 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 4 5 7 Lock Lock Lock
Equity $m Lock Lock Lock Lock 4 3 5 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 5 3 5 Lock Lock Lock
     Growth % Lock Lock Lock Lock -34.7 -31.9 53.9 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -40.7 -20.2 1.8 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -85.8 -57.5 4.6 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -55.9 -42.8 0.6 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -54.0 -44.1 5.5 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -61.3 -4.3 -72.3 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Leverage
Interest Cover X Lock Lock Lock Lock -97.7 -10.1 1.4 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 0.4 0.9 1.2 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -31.1 -54.1 7.0 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 2.3 1.5 1.6 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 1.3 1.1 1.0 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 33.4 37.2 24.0 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -117.1 -3.2 -39.3 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 6.5 6.0 5.1 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 1.5 2.2 2.5 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 1.9 5.1 4.3 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 31.4 19.2 19.5 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 1.0 1.6 1.5 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 1.0 1.6 1.5 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -47.1 -15.3 -0.7 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -45.1 -24.0 -1.0 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -40.7 -20.2 1.8 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 2.1 2.9 2.6 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -85.8 -57.5 4.6 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -85.8 -57.5 4.6 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 248.0 167.8 147.9 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 56.4 60.5 71.3 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 304.4 228.3 219.3 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 126.6 206.8 115.5 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 177.8 21.5 103.7 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.16%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

BIO Shortsell

Frequently Asked Questions

The current share price of Biome Australia Ltd (BIO:ASX) is AU$0.46.
The 52-week high share price for Biome Australia Ltd (BIO:ASX) is AU$0.87.
The 52-week low share price for Biome Australia Ltd (BIO:ASX)? is AU$0.38.
Biome Australia Ltd (BIO:ASX) does not pay a dividend.
Biome Australia Ltd (BIO:ASX) does not pay a dividend.
Biome Australia Ltd (BIO:ASX) has a franking level of 0.0%.
Biome Australia Ltd (BIO:ASX) is classified in the Healthcare.
The current P/E ratio for Biome Australia Ltd (BIO:ASX) is 545.00.
The current share price of Biome Australia Ltd (BIO:ASX) is AU$0.46.
The 52-week high share price for Biome Australia Ltd (BIO:ASX) is AU$0.87.
The 52-week low share price for Biome Australia Ltd (BIO:ASX)? is AU$0.38.
Biome Australia Ltd (BIO:ASX) does not pay a dividend.
Biome Australia Ltd (BIO:ASX) does not pay a dividend.
Biome Australia Ltd (BIO:ASX) has a franking level of 0.0%.
Biome Australia Ltd (BIO:ASX) is classified in the Healthcare.
The current P/E ratio for Biome Australia Ltd (BIO:ASX) is 545.00.
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.